About Virocan Therapeutics
Virocan Therapeutics is a company. Virocan Therapeutics offers products and services including Immunotherapy and Monoclonal Antibodies.
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Virocan Therapeutics Pvt. Ltd
- Jurisdiction Guntur, Andhra Pradesh, India
-
Annual Revenue
Not available
-
Net Profit
-$1.25 K (USD)46.1as on Mar 31, 2020
-
EBITDA
-$1.19 K (USD)50.08as on Mar 31, 2020
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Virocan Therapeutics
Virocan Therapeutics offers a comprehensive portfolio of products and services, including Immunotherapy and Monoclonal Antibodies.
Immunotherapy and gene therapy approaches are developed for various diseases, including cancer.
Novel and biosimilar monoclonal antibodies are generated for drug development in therapeutic applications.
Funding Insights of Virocan Therapeutics
Detailed funding history for Virocan Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Virocan Therapeutics
Investment portfolio details for Virocan Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Virocan Therapeutics
Detailed financials for Virocan Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Virocan Therapeutics Comparisons
Peer comparison for Virocan Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Virocan Therapeutics
Detailed competitors of Virocan Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Virocan Therapeutics
Complete news archive for Virocan Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Virocan Therapeutics
Virocan Therapeutics is recognized as a privately held biotechnology company that was established in 2006 and is involved in advanced research for cancer-specific targets, RNA inhibition, and immuno-gene therapy. Drug candidates are identified and validated through collaborations with contract research organizations and researchers in the United States, emphasizing viral gene therapy and RNA interference for effective treatments. Social services are conducted, such as distributing essentials to homeless and needy individuals in Guntur, along with support for orphanages and old age homes. The companys efforts are directed towards generating novel biologic and biosimilar products for various diseases, ensuring regulatory compliance in the process. (78 words).
Virocan Therapeutics offers Immunotherapy and Monoclonal Antibodies.